Efficacy and safety of fenofibrate for the treatment of hypertriglyceridemia associated with antiretroviral therapy

被引：18

作者：

Palacios, R ^{[1
]}

Santos, J

González, M

Ruiz, J

Valdivielso, T

Márquez, M

González-Santos, P

机构：

[1] Univ Malaga, Hosp Virgen Victoria, Infect Dis Unit, E-29071 Malaga, Spain

[2] Univ Malaga, Hosp Virgen Victoria, Lipid Unit, Med Interna Serv, E-29071 Malaga, Spain

[3] Univ Malaga, Hosp Virgen Victoria, Dept Med, E-29071 Malaga, Spain

来源：

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2002年 / 31卷 / 02期

关键词：

D O I：

10.1097/00126334-200210010-00018

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：251 / 253

页数：3

共 11 条

[1]

Brewer HB, 1999, AM J CARDIOL, V83, p3F

[2] Adverse effects of antiretroviral therapy [J].

Carr, A ;

Cooper, DA .

LANCET, 2000, 356 (9239) :1423-1430

[3]

Castelli WP, 1996, ATHEROSCLEROSIS, V124, pS1, DOI 10.1016/0021-9150(96)05851-0

[4] Micronized fenofibrate: A new fibric acid hypolipidemic agent [J].

Guay, DRP .

ANNALS OF PHARMACOTHERAPY, 1999, 33 (10) :1083-1103

[5] Atorvastatin and gemfibrozil for protease-inhibitor-related lipid abnormalities [J].

Henry, K ;

Melroe, H ;

Huebesch, J ;

Hermundson, J ;

Simpson, J .

LANCET, 1998, 352 (9133) :1031-1032

[6] Drug treatment of lipid disorders [J].

Knopp, RH .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (07) :498-511

[7]

*NAT CHOL ED PROGR, 2001, JAMA-J AM MED ASSOC, V10, P299

[8] Efficacy and safety of atorvastatin in the treatment of hypercholesterolemia associated with antiretroviral therapy [J].

Palacios, R ;

Santos, J ;

González, M ;

Ruiz, J ;

Valdivielso, P ;

Márquez, M ;

González-Santos, P .

JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 30 (05) :536-537

[9] Pancreatitis, triglycerides and highly-active antiretroviral therapy [J].

Palacios, R ;

Santos, J ;

Ruiz, J ;

Márquez, M .

MEDICINA CLINICA, 2002, 118 (02) :77-78

[10]

Penzak SR, 2000, SCAND J INFECT DIS, V32, P111

← 1 2 →